Elicio Therapeutics (ELTX) Equity Income (2020 - 2022)

Elicio Therapeutics (ELTX) reported Equity Income of $9000.0 for Q3 2022, down 70.97% on a YoY basis from $31000.0 in Q3 2021, and down 93.23% quarter-over-quarter from $133000.0 in Q2 2022.

Elicio Therapeutics (ELTX) Equity Income (2020 - 2022) Analysis & Trends

Elicio Therapeutics has reported Equity Income for 3 years, with the latest figure at $9000.0 in Q3 2022.

  • For the quarter ending Q3 2022, Equity Income fell 70.97% year-over-year to $9000.0; the trailing twelve-month figure through Mar 2023 stood at $142000.0 (up 192.21% YoY), and the FY2022 full-year result was $151000.0, up 257.29% from the prior year.
  • Equity Income for Q3 2022 stood at $9000.0, down from $133000.0 in the prior quarter.
  • The five-year high for Equity Income was $133000.0 in Q2 2022, with the low at -$172000.0 in Q4 2021.
  • Historically, Equity Income has averaged -$1600.0 across 3 years, with a median of $18500.0 in 2020.
  • Annual changes were most pronounced in 2021 — Equity Income plunged 178.57% — and 2022, when it jumped 704.55%.
  • Elicio Therapeutics' Equity Income stood at -$127000.0 in 2020, then slumped by 35.43% to -$172000.0 in 2021, then jumped by 105.23% to $9000.0 in 2022.
  • The last three Equity Income figures came in at $9000.0 (Q3 2022), $133000.0 (Q2 2022), and $9000.0 (Q1 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 235,807.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Elicio Therapeutics 70.12 Mn 55.17 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2022 9,000.00
Jun 30, 2022 133,000.00
Mar 31, 2022 9,000.00
Dec 31, 2021 -172,000.00
Sep 30, 2021 31,000.00
Jun 30, 2021 -22,000.00
Mar 31, 2021 67,000.00
Dec 31, 2020 -127,000.00
Jun 30, 2020 28,000.00
Mar 31, 2020 28,000.00